Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19
Clinical trial NCT04497948 · TERMINATED
Trial details
- NCT number
- NCT04497948
- Sponsor
- Acerta Pharma BV
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2020-11-18
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.